Further analysis unveiled that when mouse bone marrow-derived DCs (BMDCs) were treated with sialic acid blocking mimics, the viability and differentiation degree of BMDCs were not affected, but their maturation was obviously boosted, and the proliferation levels of BMDCs-induced antigen-specific CD8+ T cells were raised, impeding the progression of cancer development [93]. Here, CD8A is linked to cancer.